These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Valproate-induced hyperammonemic encephalopathy with normal liver function. Rath A; Naryanan TJ; Chowdhary GV; Murthy JM Neurol India; 2005 Jun; 53(2):226-8. PubMed ID: 16010067 [TBL] [Abstract][Full Text] [Related]
7. Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting. Dawson LP; Lee SJ; Hollander YS Aust N Z J Psychiatry; 2016 Nov; 50(11):1110. PubMed ID: 27056174 [No Abstract] [Full Text] [Related]
10. Valproate-Induced Hyperammonemic Encephalopathy in General Hospital Patients With One or More Psychiatric Disorders. Lewis C; Tesar GE; Dale R Psychosomatics; 2017; 58(4):415-420. PubMed ID: 28411969 [TBL] [Abstract][Full Text] [Related]
11. Risperidone, a risk factor for valproate-induced encephalopathy? Rodrigues-Silva N; Venâncio Â; Bouça J Gen Hosp Psychiatry; 2013; 35(4):452.e5-6. PubMed ID: 23317937 [TBL] [Abstract][Full Text] [Related]
12. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting. Dealberto MJ Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551 [TBL] [Abstract][Full Text] [Related]
13. Valproate-induced encephalopathy related to concurrent antimanic medications. Trojak B; de la Gastine B; Dollfus S J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120 [No Abstract] [Full Text] [Related]
14. Valproate-induced hyperammonemic encephalopathy: a case report. Shah S; Wang R; Vieux U J Med Case Rep; 2020 Jan; 14(1):19. PubMed ID: 31980035 [TBL] [Abstract][Full Text] [Related]
15. [Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy]. Rottach KG; Weiss-Brummer J; Wieland U; Schmauss M Nervenarzt; 2000 May; 71(5):401-3. PubMed ID: 10846716 [TBL] [Abstract][Full Text] [Related]
16. Acute akinetic crisis with marked cognitive impairment due to Valproate treatment. Reif A; Hamelbeck B; Pfuhlmann B Int J Geriatr Psychiatry; 2003 Apr; 18(4):356-7. PubMed ID: 12673616 [No Abstract] [Full Text] [Related]
17. Valproate-induced hyperammonaemia. Raja M; Azzoni A J Clin Psychopharmacol; 2002 Dec; 22(6):631-3. PubMed ID: 12454569 [No Abstract] [Full Text] [Related]
18. A case of valproate-induced encephalopathy. Hong L; Schutz J; Nance M Aust N Z J Psychiatry; 2012 Dec; 46(12):1200-1. PubMed ID: 22619383 [No Abstract] [Full Text] [Related]
19. [Inappropriate antidiuretic hormone secretion induced by sodium valproate]. Bève E; Beck E; Pinto E; Ansseau M Rev Med Liege; 2010 Jan; 65(1):6-9. PubMed ID: 20222501 [TBL] [Abstract][Full Text] [Related]
20. Treatment of valproate-induced alopecia. Fatemi SH; Calabrese JR Ann Pharmacother; 1995 Dec; 29(12):1302. PubMed ID: 8672845 [No Abstract] [Full Text] [Related] [Next] [New Search]